In Vitro Assessment of the Antidiabetic and Anti-Inflammatory Potential of Artemisia absinthium, Artemisia vulgaris and Trigonella foenum-graecum Extracts Processed Using Membrane Technologies
Molecules · 2023
DOI: 10.3390/molecules28207156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Elena Neagu und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Research and Development for Biological Sciences, Centre of Bioanalysis, 296 Splaiul Independentei, 060031 Bucharest, Romania. Hauptthemen laut MEDLINE: Artemisia absinthium, Artemisia, Trigonella. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerul Cercetării și Inovării, Ministry of Research, Innovation and Digitization, CCCDI—UEFISCDI, Core Program project.
Abstract (Originalsprache)
Recently, there has been increased interest in the discovery of new natural herbal remedies for treating diabetes and inflammatory diseases. In this context, this work analyzed the antidiabetic and anti-inflammatory potential of Artemisia absinthium, Artemisia vulgaris and Trigonella foenum-graecum herbs, which have been studied less from this point of view. Therefore, extracts were prepared and processed using membrane technologies, micro- and ultrafiltration, to concentrate the biologically active principles. The polyphenol and flavone contents in the extracts were analyzed. The qualitative analysis of the polyphenolic compounds was performed via HPLC, identifying chlorogenic acid, rosmarinic acid and rutin in A. absinthium; chlorogenic acid, luteolin and rutin in A. vulgaris; and genistin in T. foenum-graecum. The antidiabetic activity of the extracts was analyzed by testing their ability to inhibit α-amylase and α-glucosidase, and the anti-inflammatory activity was analyzed by testing their ability to inhibit hyaluronidase and lipoxygenase. Thus, the concentrated extracts of T. foenum-graecum showed high inhibitory activity on a-amylase—IC50 = 3.22 ± 0.3 μg/mL—(compared with acarbose—IC50 = 3.5 ± 0.18 μg/mL) and high inhibitory activity on LOX—IC50 = 19.69 ± 0.52 μg/mL (compared with all standards used). The concentrated extract of A. vulgaris showed increased α-amylase inhibition activity—IC50 = 8.57 ± 2.31 μg/mL—compared to acarbose IC50 = 3.5 ± 0.18 μg/mL. The concentrated extract of A. absinthium showed pronounced LOX inhibition activity—IC50 = 19.71 ± 0.79 μg/mL—compared to ibuprofen—IC50 = 20.19 ± 1.25 μg/mL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Research and Development for Biological Sciences, Centre of Bioanalysis, 296 Splaiul Independentei, 060031 Bucharest, Romania.
- Commercial Society for Medicinal Plant Research and Processing Plantavorel, 46 Cuza Voda Street, 610019 Piatra Neamt, Romania.
ORCID-Profile: Gabriela Paun, Camelia Albu, Gabriel Lucian Radu
Förderung
- Ministerul Cercetării și Inovării
- Ministry of Research, Innovation and Digitization, CCCDI—UEFISCDI
- Core Program project
Zitieren
APA
Neagu, E., Paun, G., Albu, C., Apreutesei, O. T., & Radu, G. L. (2023). In Vitro Assessment of the Antidiabetic and Anti-Inflammatory Potential of Artemisia absinthium, Artemisia vulgaris and Trigonella foenum-graecum Extracts Processed Using Membrane Technologies. Molecules. https://doi.org/10.3390/molecules28207156
Vancouver
Neagu E, Paun G, Albu C, Apreutesei OT, Radu GL. In Vitro Assessment of the Antidiabetic and Anti-Inflammatory Potential of Artemisia absinthium, Artemisia vulgaris and Trigonella foenum-graecum Extracts Processed Using Membrane Technologies. Molecules. 2023. doi:10.3390/molecules28207156
BibTeX
@article{Neagu2023,
author = {Neagu, Elena and Paun, Gabriela and Albu, Camelia and Apreutesei, Oana Teodora and Radu, Gabriel Lucian},
title = {In Vitro Assessment of the Antidiabetic and Anti-Inflammatory Potential of Artemisia absinthium, Artemisia vulgaris and Trigonella foenum-graecum Extracts Processed Using Membrane Technologies},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28207156}
}
EUVIMED